On the contrary, the scRNA-seq based transcriptomic profiling overcomes these limitations of bulk RNA-seq and enables the precise measurements of gene expressions that occur exclusively in malignant cells vs other types of cells in the tumor tissues, which permits us to annotate the HNSCC tumor cell-specific TF-IRG regulatory networks with the higher accuracy. This evidence concerns the gene TF and head and neck squamous cell carcinoma.